Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.79 USD | -2.14% | +14.40% | +108.99% |
May. 14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
May. 13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.99% | 331M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.22% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Insider Trends: Inovio Pharmaceutical Insider Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact